Cargando…

Immunogenicity of the Xcl1-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19

SARS-CoV-2 spike (S) variants that may evade antibody-mediated immunity are emerging. Evidence shows that vaccines with a stronger immune response are still effective against mutant strains. Here, we report a targeted type 1 conventional dendritic (cDC1) cell strategy for improved COVID-19 vaccine d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Hailong, Sun, Zhongjie, Yao, Yanling, Chen, Ligong, Su, Xuncheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951015/ https://www.ncbi.nlm.nih.gov/pubmed/35335039 http://dx.doi.org/10.3390/vaccines10030407

Ejemplares similares

The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
por: Sun, Zhongjie, et al.
Publicado: (2022)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

Endocytosis Deficient Murine Xcl1-Fusion Vaccine Enhances Protective Antibody Responses in Mice
por: Gudjonsson, Arnar, et al.
Publicado: (2019)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site
por: Lysén, Anna, et al.
Publicado: (2019)

Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
por: Sundaram, Appavu K., et al.
Publicado: (2021)

Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
por: Dormeshkin, Dmitri, et al.
Publicado: (2023)

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
por: Alluhaybi, Khalid A., et al.
Publicado: (2021)

Author Correction: Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site
por: Lysén, Anna, et al.
Publicado: (2020)

Traumatic brain injury in mice induces changes in the expression of the XCL1/XCR1 and XCL1/ITGA9 axes
por: Ciechanowska, Agata, et al.
Publicado: (2020)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

Transient Inhibition of the JNK Pathway Promotes Human Hematopoietic Stem Cell Quiescence and Engraftment
por: Xie, Huangfan, et al.
Publicado: (2022)

Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control
por: Botelho, Natalia K., et al.
Publicado: (2019)

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020)

Enhancement of immunogenicity and neutralizing responses against SARS-CoV-2 spike protein using the Fc fusion fragment
por: Ehteshaminia, Yahya, et al.
Publicado: (2023)

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
por: Meyer zu Natrup, Christian, et al.
Publicado: (2022)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Borgoyakova, M. B., et al.
Publicado: (2021)

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
por: Ravichandran, Supriya, et al.
Publicado: (2020)

Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
por: Malladi, Sameer Kumar, et al.
Publicado: (2020)

Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2
por: Peng, Qiaoli, et al.
Publicado: (2022)

The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2022)

Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2
por: Almansour, Iman, et al.
Publicado: (2021)

A Novel Role for Lymphotactin (XCL1) Signaling in the Nervous System: XCL1 Acts via its Receptor XCR1 to Increase Trigeminal Neuronal Excitability
por: Bird, Emma V., et al.
Publicado: (2018)

Fusion of CTA and CTB gene to immunogen significantly enhances the immunogenicity of DNA vaccine
por: Ren, X, et al.
Publicado: (2012)

The Genome of Deep-Sea Vent Chemolithoautotroph Thiomicrospira crunogena XCL-2
por: Scott, Kathleen M, et al.
Publicado: (2006)

Switchable Membrane Remodeling and Antifungal Defense by Metamorphic Chemokine XCL1
por: Dishman, Acacia F., et al.
Publicado: (2020)

New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
por: Ciechanowska, Agata, et al.
Publicado: (2022)

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
por: Leal, Lorna, et al.
Publicado: (2023)

Host cell membrane capture by the SARS-CoV-2 spike protein fusion intermediate
por: Su, Rui, et al.
Publicado: (2022)

Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits
por: O'Kennedy, Martha M, et al.
Publicado: (2023)

579. Design and Immunogenicity of a Pan-SARS-CoV-2 Synthetic DNA Vaccine
por: Schultheis, Katherine, et al.
Publicado: (2021)

Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate
por: Su, Rui, et al.
Publicado: (2023)

Study of fusion peptide release for the spike protein of SARS-CoV-2
por: Yu, Jie, et al.
Publicado: (2023)

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
por: Kakkassery, Helen, et al.
Publicado: (2022)

Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer
por: Zhou, Bing, et al.
Publicado: (2016)

Metamorphic Protein Folding Encodes Multiple Anti-Candida Mechanisms in XCL1
por: Dishman, Acacia F., et al.
Publicado: (2021)

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
por: Akache, Bassel, et al.
Publicado: (2021)

A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats
por: Tabynov, Kairat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eb3nraeptoviqiechsldvd0cvg